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Abstract
Objective: To correlate between the overactive bladder symptom score 
(OABSS) and urgency severity score (USS) in a group of patients with over-
active bladder (OAB) syndrome and evaluate the changes in these two 
measures after antimuscarinic treatment.
Materials and Methods: A total of 170 patients with clinical symptoms of 
frequency urgency were prospectively enrolled in this study. The Chinese 
version of the OABSS questionnaire, which has been linguistically vali-
dated, and the USS based on a 3-day voiding diary were recorded at base-
line. Patients with clinically diagnosed OAB were treated with solifenacin 
5 mg daily for 1 month, and the OABSS and USS were repeated at 1 week 
and 1 month. The OABSS and USS were compared at baseline, 1 week and 
1 month after treatment.
Results: The patients enrolled included 98 men and 72 women with a 
mean age of 64.1 years. A high OABSS total score was significantly asso-
ciated with a high grade of USS. There was a significant correlation 
between the two sores (R2 = 0.5520, p < 0.0001). The main contributions 
to the OABSS in patients with a low USS were daytime frequency and 
nighttime frequency. The contribution of urgency and urgency urinary 
incontinence became significant in patients with high urgency grades. 
The changes in the USS and OABSS were significant at 1 month. The 
change in frequency was significant in the daytime as well as at nighttime.
Conclusion: A strong correlation between the OABSS and USS based on 
a voiding diary was noted in patients with OAB. The changes in these two 
measures were similar after solifenacin treatment. [Tzu Chi Med J 2010;
22(2):82–86]
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1. Introduction
Overactive bladder (OAB) is a common complaint 
in the elderly. Previous epidemiological studies have 
revealed that 10–15% of the population suffer from 
various degrees of OAB [1]. Urgency is the core 
symptom of OAB. According to recommendations on 
lower urinary tract symptoms by the International 
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Continence Society, increased bladder sensation (IBS) 
is defined as a sensory symptom with a sensation of 
desire to void which occurs early during bladder fill-
ing, while urgency is defined as a bladder storage 
symptom with a sudden, compelling desire to pass 
urine which is difficult to defer [2]. The difference 
between these two symptoms is that micturition can 
be postponed despite the desire to void in IBS, but not 
in urgency. It is possible that patients with lower uri-
nary tract symptoms may not be able to differentiate 
between IBS and OAB and may report IBS as OAB.
Assessment of OAB severity is not an easy task. 
There have been several validated symptom scores 
developed for clinical use and research purposes. 
The overactive bladder symptom score (OABSS) is a 
recently designed tool to evaluate patients with OAB 
symptoms and is popular in the Asia-Pacific region [3]. 
It contains four domains dealing with daytime fre-
quency, nighttime frequency (nocturia), urgency and 
urgency urinary incontinence (UUI) episodes with a 
score from 0 to 15. A total OABSS score = 5 indicates 
OAB syndrome. This score also implies that patients 
with severe frequency (score = 2) and nocturia 
(score = 3) but no urgency can also have OAB. A strong 
correlation of bladder hypersensitivity with OAB has 
been postulated [4].
The Indevus Urgency Severity Score (IUSS) has 
also been proposed and validated.The IUSS is a sim-
ple questionnaire for patients to report the severity 
of urgency [5]. Patients might have urgency but no 
frequency because they modulate their drinking hab-
its to cope with bothersome OAB symptoms. Since 
the core symptom of OAB is urgency, the severity of 
urgency might be used to assess the clinical condi-
tion as well as treatment outcome.
This study prospectively measured the OABSS and 
USS in a group of patients with OAB syndrome and 
evaluated the changes in these two measures after 
antimuscarinic treatment.
2. Materials and methods
A total of 170 patients with clinical symptoms of fre-
quency urgency were prospectively enrolled in this 
study. Patients were requested to fill out the Chinese 
version of the OABSS questionnaire (Table 1), which 
has been linguistically validated. All patients were also 
requested to record a 3-day voiding diary and the ur-
gency severity score (USS) according to their percep-
tion of urgency severity at each urgency episode. The 
most frequently occurring USS was obtained as the 
overall USS. The OABSS was scored according to 
the recommendations of Homma et al [3]. The USS 
was adapted from the IUSS and modified by adding a 
score of 4 for an episode when a patient was unable 
to hold urine, leaked urine, or had a wetting accident 
before getting to the bathroom (Table 2). The total 
OABSS score, OABSS subscores, and USS in the void-
ing diary were correlated at baseline.
Patients with clinically diagnosed OAB were treated 
with solifenacin 5 mg daily for 1 month, and the OABSS 
and USS were repeated at 1 week and 1 month. The 
OABSS and USS were compared at baseline, 1 week 
and 1 month.
Pearson’s correlation was used to correlate the 
OABSS and USS and the paired t test was used to 
compare the changes in the OABSS and USS at base-
line and after treatment. A p value < 0.05 was con-
sidered statistically significant.
3. Results
The patients enrolled included 98 men and 72 
women with a mean age of 64.1 years old. Patients 
with a USS of 0 were significantly younger than those 
with a USS = 1 (p < 0.05). The mean OABSS by USS 
grade is shown in Table 3. A high OABSS total score 
was associated with a high USS.
Fig. 1 shows the correlation between the USS 
grade and OABSS total score. There was a significant 
correlation between the two scores (R2 = 0.5520, 
p < 0.0001). Although most patients with a USS of 0 
had an OABSS < 5, patients with OABSS < 5 had vari-
ous grades of USS. However, USS and OABSS for all 
patients were highly correlated.
Table 4 shows the contributions of the four com-
ponents of the OABSS with different USS. Patients 
with USS of 0 and USS of 1 had minimal scores for 
urgency and UUI on the OABSS. The main contribu-
tions to the OABSS in patients with low USS were 
daytime frequency and nighttime frequency. The 
contribution of urgency and UUI became significant 
in patients with high urgency grades.
The changes in USS and OABSS after solifenacin 
treatment are listed in Table 5. A total of 51 patients 
completed the trial and recordings. The changes in 
USS and OABSS were not significant at 1 week, but 
were significant at 1 month. The change in frequency 
was significant in the daytime as well as at nighttime. 
The changes in these parameters over time were 
also highly correlated between the USS and OABSS 
(p < 0.01).
4. Discussion
OAB has become an important urological syndrome 
with great impact on quality of life and emotions. 
Although there are several scoring systems and ques-
tionnaires that assess the severity of OAB and its im-
pact on quality of life, no single urological index yields 
a quantifiable and clinically interpretable measure of 
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or urgency and frequency episodes during a given 
period, but the severity of urgency is not assessed as 
a quantitative measure reflecting real life conditions. 
A composite symptom score of toilet voids, urgency 
severity, and urge urinary incontinence has been de-
veloped to better indicate the urgency severity for 
each toilet void [6].
Among OAB symptoms, urgency is the most difficult 
to measure. Most patients with OAB modify their be-
havior to prevent urgency or UUI. Therefore, they might 
report a low OAB score. Since urgency is the corner-
stone of OAB, it is essential to incorporate urgency se-
verity into the scoring system to assess the therapeutic 
effectiveness of different treatment regimens.
The OABSS comprises four symptoms: daytime 
frequency, nighttime frequency, urgency and UUI. 
The weighing score was based on a secondary analy-
sis of an epidemiological database with maximal 
Table 1 — Chinese version of the overactive bladder symptom score (OABSS)
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Table 2 — Definition of the urgency severity score
0  No feeling of urgency: patient can continue activities until he 
(she) chooses to use the bathroom.
1  Mild feeling of urgency: patient can feel the need to urinate 
but it is easily tolerated. He (she) can finish the activity or 
task before going to the bathroom.
2  Moderate feeling of urgency: sensation of urgency causes 
discomfort. He (she) needs to stop the activity or task to go
to the bathroom.
3  Severe feeling of urgency: sensation of urgency causes much 
discomfort. He (she) has difficulty holding urine. He (she) 
must stop the activity or task to hurry to the bathroom to 
avoid a wetting accident.
4  Unable to hold and leaks urine: patient has a wetting accident 
before getting to the bathroom.
OAB symptoms. Most OAB scoring systems, such as 
the International Consultation of Incontinence ques-
tionnaire (ICI-Q), OABSS, and Urogenital Distress In-
ventory short form (UDI-6), measure the frequency 
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Table 4 — Contribution of overactive bladder symptom score (OABSS) components for different urgency severity 
scores (USS)*
USS (n)
 Daytime Nighttime 
Urgency (0–5) UUI (0–5) OABSS
 frequency (0–2) frequency (0–3)
0 (42) 0.87 ± 0.56 1.20 ± 1.03 0 0 2.05 ± 1.43 (0–7)
1 (24) 1.25 ± 1.35 2.15 ± 1.59 1.35 ± 1.43 0 4.75 ± 2.47 (2–10)
2 (29) 1.15 ± 1.12 2.05 ± 1.05 2.50 ± 1.0 0.65 ± 0.41 6.31 ± 2.24 (2–9)
3 (43) 1.37 ± 1.23 2.15 ± 1.57 3.15 ± 1.29 1.12 ± 1.05 7.79 ± 2.70 (2–15)
4 (32) 1.25 ± 1.43 2.21 ± 1.05 4.07 ± 2.01 1.65 ± 1.43 9.13 ± 2.67 (5–13)
*Data presented as mean ± standard deviation or mean ± standard deviation (range).
Table 5 — Changes in urgency severity score (USS) 
and overactive bladder symptom score (OABSS) after 
antimuscarinic treatment*
 Baseline 1 wk 1 mo
 (n = 51) (n = 51) (n = 51)
USS 3.20 ± 0.98 3.08 ± 1.04 1.96 ± 1.17†
OABSS 7.70 ± 2.76 7.58 ± 2.87 5.90 ± 3.14†
Daytime frequency 9.52 ± 2.77 7.10 ± 2.83 6.48 ± 2.61†
Nighttime frequency 4.16 ± 2.96 4.14 ± 2.98 3.41 ± 2.04†
*Data presented as mean ± standard deviation; †p < 0.05 compared 
to baseline data.
Table 3 — Demographic characteristics of patients with 
different urgency severity scores (USS) and the corre-
sponding overactive bladder symptom score (OABSS)*
USS N Male Female Age (yr) OABSS
0  42 13 29 45.9 ± 19.7 2.05 ± 1.43 (0–7)
1  24 18  6 61.8 ± 16.8 4.75 ± 2.47 (2–10)
2  29 16 13 71.4 ± 8.9 6.31 ± 2.24 (2–9)
3  43 24 19 70.5 ± 13.3 7.79 ± 2.70 (2–15)
4  32 27  5 74.4 ± 11.6 9.13 ± 2.67 (5–13)
Total 170 98 72 64.1 ± 18.4
*Data presented as n or mean ± standard deviation or mean ± standard 
deviation (range).
Fig. 1 — Correlation between overactive bladder symp-
tom score (OABSS) and urgency severity score (USS).
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scores of 2, 3, 5 and 5 for individual symptoms. The 
sum score was significantly greater in the patients 
with OAB than in the groups of patients with stress 
urinary incontinence, benign prostatic hyperplasia, 
and asymptomatic controls [3]. The OABSS has been 
found to be closely correlated with patient percep-
tions of their bladder condition and OAB-q subscales 
of health-related quality of life, indicating that the 
OABSS sufficiently reflects the severity of patient 
perceptions of urgency [7].
The results of this study further demonstrate that 
the OABSS can reflect the severity of urgency in real 
life in patients with OAB. Although a total of 170 pa-
tients with frequency urgency symptoms were pro-
spectively enrolled, the USS was 0 in 42 and 1 in 24, 
indicating that a large proportion of patients did not 
have significant OAB symptoms impacting their daily 
life. The OABSS total score also reflected this condi-
tion with a mean score of 2.05 for a USS of 0 and 
4.75 for a USS of 1. IBS without urgency has been 
considered a subgroup or an early form in OAB. If we 
choose a strict definition of OAB, patients with a USS 
of 0 on a voiding diary should not be included in the 
OAB group. This result further implicates the impor-
tance of a voiding diary in the differential diagnosis 
of OAB.
The results of this study showed that the higher 
the OABSS, the higher the USS grade. Analysis of the 
components of the OABSS for different USS also re-
vealed that the main contributors to the OABSS in 
patients with a USS of 0 and a USS of 1 were fre-
quency in the daytime and nighttime, and the contri-
butions of urgency and the UUI component were 
minimal for the low urgency grades. According to the 
construction of the OABSS, patients with only daytime 
frequency and nocturia but no urgency or UUI may 
also be included in the OAB group, while patients 
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with mild urgency without frequency and nocturia 
might also be excluded. This could be the cause for 
the wide distribution of the OABSS in patients with 
low USS in this study.
From the therapeutic results, we can observe a 
parallel decrease of the OABSS and USS at 1 month 
compared with baseline. Solifenacin has been dem-
onstrated to be well tolerated and to significantly im-
prove OAB symptoms compared with placebo [8]. 
This study also confirmed that solifenacin has sig-
nificant therapeutic effects not only in reduction of 
daytime and nighttime frequency, but also in the 
OABSS as well as urgency severity.
5. Conclusion
A strong correlation between the OABSS and USS 
based on a voiding diary was noted in patients with 
OAB and the changes in these two measures were 
similar after solifenacin treatment.
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